Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes

被引：0

作者：

Marx, Nikolaus ^{[1
]}

Mueller-Wieland, Dirk ^{[1
]}

Espinola-Klein, Christine ^{[2
]}

Halle, Martin ^{[3
]}

Birkenhagen, Annette ^{[4
]}

Diemert, Patrick ^{[5
]}

Mahfoud, Felix ^{[6
,9
]}

Wienbergen, Harm ^{[7
,8
]}

Schuett, Katharina ^{[1
]}

机构：

[1] Uniklin RTWH Aachen, Med Klin Kardiol Angiol & Internist Intensivmed 1, Pauwelsstr 30, D-52074 Aachen, Germany

[2] Univ Med Mainz, Zent Kardiol, Kardiol Angiol 3, Mainz, Germany

[3] Tech Univ Munich, TUM Sch Med & Hlth, Pravent Sportmed & Sportkardiol, TUM Univ klinikum rechts Isar, Munich, Germany

[4] Kardiol Angiol Praxis, Stollberg, Germany

[5] Univ Herz & Gefasszentrum Hamburg, Klinik & Poliklin Kardiol, Hamburg, Germany

[6] Univ klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intensi, Homburg, Germany

[7] Bremer Inst Herz & Kreislaufforsch, Stiftung Bremer Herzen, Gesundheit Nord Klinikverbund Bremen, Bremen, Germany

[8] Univ Lubeck, Med Klin 2, Lubeck, Germany

[9] Deutsch Gesell Kardiol Herz & Kreislaufforsch eV D, Kommiss Klin Kardiovask Med, Dusseldorf, Germany

来源：

KARDIOLOGIE | 2024年 / 18卷 / 03期

关键词：

Diabetes mellitus; Cardiovascular disease; Heart failure; Kidney failure; EJECTION FRACTION; KIDNEY OUTCOMES; HEART-FAILURE; TYPE-2; EMPAGLIFLOZIN; METAANALYSIS; FINERENONE; MORTALITY;

D O I：

10.1007/s12181-024-00689-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

引用

页码：256 / 265

页数：10

共 50 条

[1] Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes
Ruiz, Raquel Campuzano
Ramos, Pilar Mazon
Conde, Almudena Castro
Alvarez, Belen Cid
Alvarez, Concepcion Cruzado
Diez-Villanueva, Pablo
Olmo, Rosa Fernandez
Freixa-Pamias, Roman
Martin, Domingo Marzal
Perez, Sonia Mirabet
Ferreiro, Jose Luis
Avanzas, Pablo
Andrea, Rut
Boraita, Araceli
Calvo, David
Campuzano, Raquel
Delgado, Victoria
Dos Subira, Laura
Doblas, Juan Jose Gomez
Momblan, Maria Antonia Martinez
Mazon, Pilar
Figal, Domingo Pascual
Sanchis, Juan
Hernandez, Jose Maria de la Torre
Vivas, David
REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (03): : 196 - 200
[2] Comments on the ESC Guidelines on Diabetes, Prediabetes, and Cardiovascular Diseases
Mazon, Pilar
Diaz-Buschmann, Isabel
Alegria, Eduardo
Cordero, Alberto
Delgado, Elias
Facila, Lorenzo
Garcia-Moll, Xavier
de la Hera, Jesus
Murga, Nekane
Pedreira, Milagros
Aros, Fernando
Bertomeu-Martinez, Vicente
Castro, Almudena
Dalmau, Regina
Galve, Enrique
Lekuona, Inaki
de Sa, Esteban Lopez
Quiles, Juan
Vidal-Perez, Rafael
Gomez, Angel Alonso
Sanchez, Manuel Anguita
Fillat, Angel Cequier
Colet, Josep Comin
Diaz-Buschmann, Isabel
Fernandez-Lozano, Ignacio
Ortiz, Antonio Fernandez
de Diego, Jose J. Gomez
Alvarez-Osorio, Manuel Pan
Diz, Fernando Worner
REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (02): : 87 - 93
[3] Comments on the ESC guidelines (2019) on diabetes, prediabetes and cardiovascular diseases
Marx, N.
Frantz, S.
Gitt, A. K.
Zirlik, A.
KARDIOLOGE, 2020, 14 (03): : 162 - 167
[4] The′10 commandments′ for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Schuett, Katharina
Federici, Massimo
Verket, Marlo
Marx, Nikolaus
Mueller-Wieland, Dirk
EUROPEAN HEART JOURNAL, 2024,
[5] Comments on the 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases
Jorsal, Anders
Persson, Frederik
Bruun, Jens Meldgaard
EUROPEAN HEART JOURNAL, 2020, 41 (02) : 328 - 328
[6] Comments on the 2019 ESC guidelines on diabetes, pre-diabetes and cardiovascular diseases
Jimenez Navarro, Manuel
Castro, Almudena
Ballesteros Pradas, Sara
Cruzado Alvarez, Concepcion
Gomez Doblas, Juan Jose
Marzal Martin, Domingo
del Prado, Susana
Valencia Serrano, Felix
Breton, Irene
Gomez Peralta, Fernando
Mauricio, Didac
Soto Gonzalez, Alfonso
REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (05): : 354 - 360
[7] Comments on the 2013 ESC/EASD guidelines on diabetes, prediabetes and cardiovascular diseases
Motz, W.
Kerner, W.
Doerr, R.
HERZ, 2014, 39 (08) : 971 - 982
[8] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Gaps in cardiovascular risk categories
Torres-Conde, S.
Buitrago-Ramirez, F.
MEDICINA DE FAMILIA-SEMERGEN, 2025, 51 (03):
[9] Comments on the guidelines (2018) of the ESC on the management of cardiovascular diseases during pregnancy
Seeland, U.
Bauersachs, J.
Kintscher, U.
Hilfiker-Kleiner, D.
Roos-Hesselink, J. W.
Regitz-Zagrosek, V.
KARDIOLOGE, 2019, 13 (03): : 138 - 145
[10] Comments on the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy
Navarro, Manuel Jimenez
Galian-Gay, Laura
Avanzas, Pablo
Ballesteros, Sara
Garcia, Ana Gonzalez
Mesa, Ernesto Gonzalez
Bendayan, Isaac Martinez
Domenech, Antonia Pijuan
Prieto, Raquel
Subirana, Teresa
Bartha, Jose Luis
Caro, Juan
Delgado, Juan Luis
Manso, Begona
Rosillo, Sandra
Zabala, J. Ignacio
Alfonso, Fernando
Ibanez, Borja
Arribas, Fernando
Congost, Gemma Berga
Bueno, Hector
Evangelista, Arturo
Ferreira-Gonzalez, Ignacio
Navarro, Manuel Jimenez
Marin, Francisco
de Isla, Leopoldo Perez
Sambola, Antonia
Vazquez, Rafael
Viana-Tejedor, Ana
REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (02): : 109 - 114

← 1 2 3 4 5 →